Cellular characteristics of acute leukemia cells simultaneously expressing CD13/CD33, CD7 and CD19

International Journal of Hematology

Volumn 66, Issue 4, 1997, Pages 479-491

  Mizutani, Minoru ^a   Miwa, Hiroshi ^a   Takahashi, Takahiro ^a   Katoh, Keizoh ^a   Shikami, Masato ^a   Katayama, Naoyuki ^a   Shiku, Hiroshi ^a   Kita, Kenkichi ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute leukemia; CD19; CD7; Multi lineage

Indexed keywords

CD19 ANTIGEN; CD33 ANTIGEN; CD7 ANTIGEN; MICROSOMAL AMINOPEPTIDASE;

ACUTE LYMPHOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; CELL LINEAGE; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; T CELL LEUKEMIA;

EID: 0031430685     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(97)00062-5     Document Type: Article

References (33)

1. Foon KA, Todd III RF. Immunologic classification of leukemia and lymphoma. Blood 1986;68:1-31.
2. Greaves MF, Chan LC, Furley AJW, Watt SM, Morlgaard HV. Lineage promiscuity in hematopoietic differentiation and leukemia. Blood 1986;67:1-11.
3. Gale RP, Bassat IB. Hybrid acute leukemia. Br J Haematol 1987;65:261-264.
4. Cross AH, Goorha RM, Nuss R et al. Acute myeloid leukemia with T-lymphoid features: a distinct biologic and clinical entity. Blood 1988;72:579-587.
5. Ball ED, Davis RB, Griffin JD et al. Prognositic value of lymphocyte surface markers in acute myeloid leukemia. Blood 1991;77:2242-2250.
6. Nishii K, Kita K, Miwa H et al. c-kit gene expression in CD7-positive acute lymphoblastic leukemia: close correlation with expression of myeloid-associated antigen CD13. Leukemia 1992;6:662-668.
7. Kita K, Nishii K, Ohishi K et al. Frequent gene expression of granulocyte colony-stimulating factor (G-CSF) receptor in CD7+ surface CD3- acute lymphoblastic leukaemia. Leukemia 1993;8:1184-1190.
8. Kurtzberg J, Waldmann TA, Davey MP et al. CD7+CD4-CD8- acute leukemia: a syndrome of malignant pluripotent lymphohematopoietic cells. Blood 1989;73:381-390.
9. Vodinelich L, Tax W, Bai Y, Pegram S, Capel P. Greaves MF. A monoclonal antibody (WT1) for detecting leukemias of T-cell precursors (T-ALL). Blood 1983;62:1108-1113.
10. Cuneo A, Michaux JL, Ferrant A. Correlation of cytogenetic patterns and clinicobiological features in adult acute myeloid leukemia expressing lymphoid markers. Blood 1992;79:720-727.
11. Kita K, Nakase K, Miwa H et al. Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood 1992;80:470-477.
12. Claxton DF, Reading CL, Nagarajan L et al. Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia. Blood 1992;80:582-586.
13. Kita K, Miwa H, Nakase K et al. Clinical importance of CD7 expression in acute myelocytic leukemia. Blood 1993;81:2399-2405.
14. Nadler LM, Korsmeyer SJ, Anderson KC et al. B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation. J Clin Invest 1984;74:332-340.
15. Bennett JM, Catovsky D, Daniel MT et al. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Int Med 1985;103:620-625.
16. Bennett JM, Catovsky D, Daniel MT et al. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-M0). Br J Haematol 1991;78:325-329.
17. Nosaka T, Kita K, Miwa H et al. Cross-lineage gene rearrangements in human leukemic B-precursor cells occur frequently with V-DJ rearrangements of IgH genes. Blood 1989;74:361-368.
18. Takihara Y, Tkachuk D, Michalopoulos E et al. Sequence and organization of the diversity, joining, and constant region genes of the human T-cell δ-chain locus. Proc Natl Acad Sci USA 1988;85:6097-6101.
19. + acute myeloblastic leukemia/acute lymphoblastic leukemia. Blood 1993;82:3445-3451.
20. Chen CJ, Chin JE, Ueda K et al. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 1986;47:381-389.
21. Dorfman DM, Wilson DB, Bruns GAP, Orkin SH. Human transcription factor GATA-2. J Biol Chem 1992;267:1279-1285.
22. Begley CG, Aplan PD, Denning SM, Haynes BF, Waldmann TA, Kirsch IR. The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc Natl Acad Sci USA 1989;86:10128-10132.
23. Nakajima-Iijima S, Hamada H, Reddy P, Kakunaga T. Molecular structure of the human cytoplasmic β-actin gene: interspecies homology of sequences in the introns. Proc Natl Acad Sci USA 1985;82:6133-6137.
24. Brito-Babapulle F, Catovsky D, Galton DAG. Clinical and laboratory features of de novo acute myeloid leukaemia with trilineage myelodysplasia. Br J Haematol 1987;66:445-450.
25. Bradstock KF, Kirk J, Grimsley PG, Kabral A, Hughes WG. Unusual immunophenotypes in acute leukaemias: incidence and clinical correlations. Br J Haematol 1989;72:512-518.
26. Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH. Antigenic analysis of hematopoiesis: III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 1984;133:157-165.
27. Shivdasani RA, Orkin SH. The transcriptional control of hematopoiesis. Blood 1996;87:4025-4039.
28. Chaudhary PM, Roninson IB, Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 1991;66:85-94.
29. Lo Coco F, De Rossi G, Pasqualetti D et al. CD7 positive acute myeloid leukaemia: a subtype associated with cell immaturity. Br J Haematol 1989;73:480-485.
30. Hurwitz CA, Raimondi SC, Head D et al. Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children. Blood 1992;80:3182-3188.
31. Janossy G, Coustan-Smith E, Campana D. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases. Leukemia 1989;3:170-181.
32. Robb L, Lyons I, Li R, Hartley L et al. Absense of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc Natl Acad Sci USA 1995;92:7075-7079.
33. Shimamoto T, Ohyashiki K, Ohyashiki JH et al. The expression pattern of erythrocyte/megakaryocyte-related transcriptional factors GATA-1 and stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia. Blood 1995;86:3173-3180.